CRBP – Corbus Pharmaceuticals Holdings Inc.
CRBP — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
8.49
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
0.03
EPS Last/This Y
1.04
EPS This/Next Y
-0.08
Price
9.77
Target Price
42.22
Analyst Recom
1
Performance Q
24.01
Upside
-900.6%
Beta
2.89
Ticker: CRBP
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | CRBP | 9.51 | 0.03 | 0.00 | 8676 |
| 2026-03-10 | CRBP | 10.1 | 0.03 | 0.00 | 8976 |
| 2026-03-11 | CRBP | 10.38 | 0.03 | 0.00 | 9048 |
| 2026-03-12 | CRBP | 9.56 | 0.02 | 0.00 | 9759 |
| 2026-03-13 | CRBP | 9.59 | 0.02 | 0.00 | 9759 |
| 2026-03-17 | CRBP | 9.6 | 0.03 | 0.15 | 9781 |
| 2026-03-18 | CRBP | 9.05 | 0.03 | 0.01 | 9835 |
| 2026-03-19 | CRBP | 8.95 | 0.03 | 0.05 | 9969 |
| 2026-03-20 | CRBP | 8.61 | 0.03 | 0.03 | 9959 |
| 2026-03-23 | CRBP | 8.38 | 0.02 | 0.00 | 8403 |
| 2026-03-24 | CRBP | 8.21 | 0.01 | 0.00 | 10295 |
| 2026-03-25 | CRBP | 8.28 | 0.01 | 0.01 | 11110 |
| 2026-03-26 | CRBP | 9.26 | 0.01 | 0.31 | 12081 |
| 2026-03-27 | CRBP | 8.74 | 0.19 | 0.22 | 16050 |
| 2026-03-30 | CRBP | 8.59 | 0.19 | 0.00 | 16101 |
| 2026-03-31 | CRBP | 9.35 | 0.21 | 0.46 | 14663 |
| 2026-04-01 | CRBP | 10.01 | 0.21 | 0.13 | 14697 |
| 2026-04-02 | CRBP | 10.2 | 0.21 | 0.00 | 14852 |
| 2026-04-06 | CRBP | 10.08 | 0.20 | 0.01 | 15187 |
| 2026-04-07 | CRBP | 9.71 | 0.20 | 0.00 | 15447 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | CRBP | 9.52 | -102.0 | -105.4 | -6.71 |
| 2026-03-10 | CRBP | 10.08 | -102.0 | -50.1 | -6.71 |
| 2026-03-11 | CRBP | 10.42 | -102.0 | -43.6 | -6.71 |
| 2026-03-12 | CRBP | 9.60 | -102.0 | -14.9 | -6.71 |
| 2026-03-13 | CRBP | 9.40 | 14.0 | -27.3 | -4.86 |
| 2026-03-17 | CRBP | 9.62 | 14.0 | -34.5 | -4.86 |
| 2026-03-18 | CRBP | 9.05 | 14.0 | -17.9 | -4.86 |
| 2026-03-19 | CRBP | 8.91 | 14.0 | -28.2 | -4.86 |
| 2026-03-20 | CRBP | 8.61 | 14.0 | -21.2 | -4.86 |
| 2026-03-23 | CRBP | 8.40 | 14.0 | -26.0 | -4.86 |
| 2026-03-24 | CRBP | 8.19 | 14.0 | 119.1 | -4.86 |
| 2026-03-25 | CRBP | 8.28 | 14.0 | 114.9 | -4.86 |
| 2026-03-26 | CRBP | 9.26 | 14.0 | 71.5 | -4.86 |
| 2026-03-27 | CRBP | 8.77 | 14.0 | 297.8 | -4.86 |
| 2026-03-30 | CRBP | 8.60 | 14.0 | 100.6 | -4.86 |
| 2026-03-31 | CRBP | 9.39 | 14.0 | 66.2 | -4.86 |
| 2026-04-01 | CRBP | 10.01 | 14.0 | -300.8 | -4.86 |
| 2026-04-02 | CRBP | 10.26 | 14.0 | -58.2 | -4.86 |
| 2026-04-06 | CRBP | 10.07 | 14.0 | -5.4 | -4.86 |
| 2026-04-07 | CRBP | 9.77 | 14.0 | 12.5 | -4.86 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | CRBP | -4.71 | 31.85 | 8.47 |
| 2026-03-10 | CRBP | -4.71 | 31.85 | 8.47 |
| 2026-03-11 | CRBP | -4.71 | 31.85 | 8.51 |
| 2026-03-12 | CRBP | -4.66 | 31.85 | 8.42 |
| 2026-03-13 | CRBP | -4.66 | 31.85 | 8.42 |
| 2026-03-17 | CRBP | -4.66 | 31.63 | 8.42 |
| 2026-03-18 | CRBP | -4.66 | 31.63 | 8.42 |
| 2026-03-19 | CRBP | -4.66 | 31.63 | 8.42 |
| 2026-03-20 | CRBP | -4.66 | 31.63 | 8.42 |
| 2026-03-23 | CRBP | -4.66 | 31.63 | 8.42 |
| 2026-03-24 | CRBP | -4.66 | 31.63 | 8.42 |
| 2026-03-25 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-03-26 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-03-27 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-03-30 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-03-31 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-04-01 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-04-02 | CRBP | -4.66 | 31.63 | 8.49 |
| 2026-04-06 | CRBP | -4.66 | 31.67 | 8.49 |
| 2026-04-07 | CRBP | -4.66 | 31.67 | 8.49 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.25
Avg. EPS Est. Current Quarter
-1.2
Avg. EPS Est. Next Quarter
-1.22
Insider Transactions
-4.66
Institutional Transactions
31.67
Beta
2.89
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
22
Sentiment Score
94
Actual DrawDown %
85.8
Max Drawdown 5-Year %
-96.8
Target Price
42.22
P/E
Forward P/E
PEG
P/S
P/B
1.16
P/Free Cash Flow
EPS
-5.98
Average EPS Est. Cur. Y
-4.86
EPS Next Y. (Est.)
-4.94
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.32
Return on Equity vs Sector %
-80.7
Return on Equity vs Industry %
-64.2
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.35
EBIT Estimation
12.5
◆
CRBP
Healthcare
$9.71
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
56.9
Range 1M
75.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
22.2%
EPS NY
-6.8%
52W%
31.9%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+334.8% upside
Upside
+334.8%
Quality
7
Corbus Pharmaceuticals HoldingsSector: Healthcare
Industry: Biotechnology
Employees: 36
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
CRBP
Latest News
—
Caricamento notizie per CRBP…
stock quote shares CRBP – Corbus Pharmaceuticals Holdings Inc. Stock Price stock today
news today CRBP – Corbus Pharmaceuticals Holdings Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRBP – Corbus Pharmaceuticals Holdings Inc. yahoo finance google finance
stock history CRBP – Corbus Pharmaceuticals Holdings Inc. invest stock market
stock prices CRBP premarket after hours
ticker CRBP fair value insiders trading